Proficio Capital Partners LLC Acquires 222,956 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Proficio Capital Partners LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 43,546.1% during the 4th quarter, Holdings Channel reports. The firm owned 223,468 shares of the company’s stock after purchasing an additional 222,956 shares during the period. Proficio Capital Partners LLC’s holdings in HCA Healthcare were worth $67,074,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Whipplewood Advisors LLC bought a new position in HCA Healthcare in the fourth quarter valued at approximately $31,000. Legacy Investment Solutions LLC bought a new position in HCA Healthcare in the third quarter valued at approximately $39,000. Activest Wealth Management increased its stake in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after acquiring an additional 125 shares during the last quarter. Capital Performance Advisors LLP bought a new position in HCA Healthcare in the third quarter valued at approximately $41,000. Finally, Pinnacle Bancorp Inc. boosted its position in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 0.2 %

HCA opened at $320.55 on Friday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The company has a fifty day moving average price of $315.11 and a two-hundred day moving average price of $349.91. The company has a market cap of $79.60 billion, a P/E ratio of 14.59, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the firm earned $5.90 earnings per share. Analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.90%. HCA Healthcare’s payout ratio is 13.11%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HCA. Truist Financial cut their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Morgan Stanley cut their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Bank of America cut their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Royal Bank of Canada cut their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. Finally, Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $385.67.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.